DK0515940T3 - Nye 2-amino-5-cyano-1,4-dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler - Google Patents

Nye 2-amino-5-cyano-1,4-dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler

Info

Publication number
DK0515940T3
DK0515940T3 DK92108324.2T DK92108324T DK0515940T3 DK 0515940 T3 DK0515940 T3 DK 0515940T3 DK 92108324 T DK92108324 T DK 92108324T DK 0515940 T3 DK0515940 T3 DK 0515940T3
Authority
DK
Denmark
Prior art keywords
dihydropyridines
cyano
amino
preparation
new
Prior art date
Application number
DK92108324.2T
Other languages
Danish (da)
English (en)
Inventor
Horst Dr Boeshagen
Juergen Dipl-Ing Stoltefuss
Siegfried Dr Goldmann
Alexander Dr Straub
Siegbert Dr Hebisch
Martin Dr Bechem
Rainer Prof Dr Gross
Joachim Dr Huetter
Howard-Paul Dr Rounding
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0515940T3 publication Critical patent/DK0515940T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK92108324.2T 1991-05-30 1992-05-18 Nye 2-amino-5-cyano-1,4-dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler DK0515940T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4117750A DE4117750A1 (de) 1991-05-30 1991-05-30 Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (1)

Publication Number Publication Date
DK0515940T3 true DK0515940T3 (da) 1996-11-25

Family

ID=6432811

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92108324.2T DK0515940T3 (da) 1991-05-30 1992-05-18 Nye 2-amino-5-cyano-1,4-dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler

Country Status (22)

Country Link
US (3) US5225558A (fi)
EP (1) EP0515940B1 (fi)
JP (1) JPH05186459A (fi)
KR (1) KR920021530A (fi)
AT (1) ATE140455T1 (fi)
AU (2) AU656374B2 (fi)
CA (1) CA2069860A1 (fi)
CZ (1) CZ158692A3 (fi)
DE (2) DE4117750A1 (fi)
DK (1) DK0515940T3 (fi)
ES (1) ES2089286T3 (fi)
FI (1) FI922428A (fi)
GR (1) GR3020575T3 (fi)
HU (2) HUT61538A (fi)
IE (1) IE921771A1 (fi)
IL (3) IL102032A (fi)
MX (1) MX9202366A (fi)
NO (2) NO921906L (fi)
NZ (2) NZ242932A (fi)
RU (1) RU2081872C1 (fi)
SK (1) SK158692A3 (fi)
ZA (1) ZA923935B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683819B1 (fr) * 1991-10-28 1994-02-11 Synthelabo Derives de quinoleine, leur procede de preparation et leur application en therapeutique.
DE69224150T2 (de) * 1991-11-12 1998-10-15 Coatex Sa Mahl- und/oder Dispersionshilfsmittel auf Basis von Polymeren und/oder teilweise durch Magnesium neutralisierten Kopolymeren für wässerige Suspensionen von mineralen Materialien, welche sich eignen für pigmentäre Anwendungen
DE4233586A1 (de) * 1992-10-06 1994-04-07 Bayer Ag 3-Imino-3-alkoxy-propionsäurelactate und deren tautomere Acrylsäurelactate
DE4313695A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-5-cyano-4-chinolyldihydropyridinester, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313696A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-4-heteroaryl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313692A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 3-Chinolyl substituierte Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4313691A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2,6-Disubstituierte 4-Chinolyl-dihydropyridine
DE4313693A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-4-chinolin-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung
DE4313697A1 (de) * 1993-04-27 1994-11-03 Bayer Ag Chinolyl-dihydropyridinester, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE4432378A1 (de) * 1994-09-12 1996-03-14 Bayer Ag Injizierbare liposomale Arzneizubereitungen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2359329A (en) * 1943-06-18 1944-10-03 Burroughs Wellcome Co Quinoline substituted dihydropyridines
US4001258A (en) * 1972-03-06 1977-01-04 Bayer Aktiengesellschaft 2-amino-1,4-dihydropyridine derivatives
US3996234A (en) * 1972-04-18 1976-12-07 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
US3989708A (en) * 1972-08-31 1976-11-02 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
DE2242786A1 (de) * 1972-08-31 1974-03-14 Bayer Ag Verfahren zur herstellung von neuen 2-amino-1,4-dihydropyridinen mit einer carbonylfunktion sowie ihre verwendung als arzneimittel
DE2310747A1 (de) * 1973-03-03 1974-09-12 Bayer Ag Verfahren zur herstellung von neuen amino-3,4-dihydropyridinen und ihre verwendung als arzneimittel
US4002762A (en) * 1973-03-03 1977-01-11 Bayer Aktiengesellschaft 2-Amino-3,4-dihydropyridines used to effect coronary vessel dilation and treat hypertension
DE2412750A1 (de) * 1974-03-16 1975-09-18 Bayer Ag Verfahren zur herstellung von 4-amino2,2,6,6-tetramethyl-piperidin
DE2623170C2 (de) * 1976-05-22 1982-03-11 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von α-Cyanzimtaldehyd-Derivaten und 3,4,5-Trimethoxy-α-Cyanzimtaldehyd
DE2658804A1 (de) * 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE3015219A1 (de) * 1980-04-19 1981-10-22 Bayer Ag, 5090 Leverkusen 6-amino-4,5-dihydropyridin-3-carbonsaeureester, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3134945A1 (de) * 1981-09-03 1983-03-17 Bayer Ag, 5090 Leverkusen Substituierte 2-amino-3,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
US5001381A (en) * 1987-12-08 1991-03-19 Akio Takahashi Electro-static motor
DE4011105A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue 4-chinolyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
HU9201799D0 (en) 1992-08-28
IL116384A (en) 1996-10-16
DE59206772D1 (de) 1996-08-22
HUT61538A (en) 1993-01-28
IL102032A (en) 1996-06-18
IE921771A1 (en) 1992-12-02
US5432282A (en) 1995-07-11
EP0515940A1 (de) 1992-12-02
GR3020575T3 (en) 1996-10-31
NO970573L (no) 1992-12-01
FI922428A (fi) 1992-12-01
NZ242932A (en) 1995-06-27
HU211579A9 (en) 1995-12-28
ES2089286T3 (es) 1996-10-01
AU1604592A (en) 1992-12-03
AU656374B2 (en) 1995-02-02
KR920021530A (ko) 1992-12-18
ZA923935B (en) 1993-02-24
NO970573D0 (no) 1997-02-07
DE4117750A1 (de) 1992-12-24
ATE140455T1 (de) 1996-08-15
SK158692A3 (en) 1995-03-08
NO921906D0 (no) 1992-05-14
EP0515940B1 (de) 1996-07-17
MX9202366A (es) 1992-11-01
NO921906L (no) 1992-12-01
JPH05186459A (ja) 1993-07-27
IL102032A0 (en) 1992-12-30
FI922428A0 (fi) 1992-05-27
CZ158692A3 (en) 1993-07-14
US5380851A (en) 1995-01-10
IL116384A0 (en) 1996-03-31
AU1619995A (en) 1995-08-03
NZ264151A (en) 1995-06-27
RU2081872C1 (ru) 1997-06-20
US5225558A (en) 1993-07-06
CA2069860A1 (en) 1992-12-01

Similar Documents

Publication Publication Date Title
NO992400L (no) Nye substituerte pyrazolderivater
NO991732L (no) Nye heterocyklylmetylsubstituerte pyrazolderivater
NO963499L (no) Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav
CS145091A3 (en) Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application
ATE233738T1 (de) Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
ATE136030T1 (de) Azaheterocyclylmethyl-chromane als wirkstoffe zur behandlung von erkrankungen des zentralnervensystems
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
NO963850L (no) Heterosykliske forbindelser, deres fremstilling og anvendelse
DK0515940T3 (da) Nye 2-amino-5-cyano-1,4-dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
ATE188873T1 (de) Tris-platin-komplexe
ES2058343T3 (es) Piridinas disubstituidas.
ATE322244T1 (de) Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen
NO884671D0 (no) Nye flourmetoksyfenyldihydropyridiner, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DK0505400T3 (da) N-substituerede naphthalimider, deres fremstilling og anvendelse
IE870577L (en) Topical amide preparation
DK0519291T3 (da) Aminomethylsubstituerede 2,3-dihydropyrano(2,3-b)-pyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
TR199901385T2 (xx) Piperidin t�revleri.
DE59808541D1 (de) Verlängerung der expression von transgenen proteinen durch immunmodulierende behandlung mit 15-deoxyspergualin
NO923455D0 (no) Indolsulfonamidsubstituert dihydropyridin, fremgangsmaate for fremstilling og anvendelse i legemidler
NO884672D0 (no) Nye fluormetoksyfenyl-dihydropyridiner, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler.
TR200000916T2 (tr) İkameli piperidin türevleri.